These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 30525252)

  • 21. Risk of fungemia due to Rhodotorula and antifungal susceptibility testing of Rhodotorula isolates.
    Zaas AK; Boyce M; Schell W; Lodge BA; Miller JL; Perfect JR
    J Clin Microbiol; 2003 Nov; 41(11):5233-5. PubMed ID: 14605170
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cost-benefit assessment of antifungal prophylaxis with liposomal amphotericin B in neutropenic patients.
    Penack O; Reinhold T; Thiel E; Blau IW
    Onkologie; 2007 Dec; 30(12):621-6. PubMed ID: 18063874
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rhodotorula mucilaginosa outbreak in neonatal intensive care unit: microbiological features, clinical presentation, and analysis of related variables.
    Perniola R; Faneschi ML; Manso E; Pizzolante M; Rizzo A; Sticchi Damiani A; Longo R
    Eur J Clin Microbiol Infect Dis; 2006 Mar; 25(3):193-6. PubMed ID: 16525775
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of primary antifungal prophylaxis in patients with haematological malignancies.
    Pagano L; Caira M
    Clin Microbiol Infect; 2014 Jun; 20 Suppl 6():19-26. PubMed ID: 24372659
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rhodotorula infection. A systematic review of 128 cases from literature.
    Tuon FF; Costa SF
    Rev Iberoam Micol; 2008 Sep; 25(3):135-40. PubMed ID: 18785780
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fungal infections of the central nervous system and paranasal sinuses in onco-haematologic patients. Epidemiological study reporting the diagnostic-therapeutic approach and outcome in 89 cases.
    Candoni A; Klimko N; Busca A; Di Blasi R; Shadrivova O; Cesaro S; Zannier ME; Verga L; Forghieri F; Calore E; Nadali G; Simonetti E; Muggeo P; Quinto AM; Castagnola C; Cellini M; Del Principe MI; Fracchiolla N; Melillo L; Piedimonte M; Zama D; Farina F; Giusti D; Mosna F; Capelli D; Delia M; Picardi M; Decembrino N; Perruccio K; Vallero S; Aversa F; Fanin R; Pagano L;
    Mycoses; 2019 Mar; 62(3):252-260. PubMed ID: 30565742
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epidemiology of candidemia in patients with hematologic malignancies and solid tumours in Brazil.
    Bergamasco MD; Garnica M; Colombo AL; Nucci M
    Mycoses; 2013 May; 56(3):256-63. PubMed ID: 23043234
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Low-dose amphotericin B lipid complex vs. conventional amphotericin B for empirical antifungal therapy of neutropenic fever in patients with hematologic malignancies--a randomized, controlled trial.
    Subirà M; Martino R; Gómez L; Martí JM; Estany C; Sierra J
    Eur J Haematol; 2004 May; 72(5):342-7. PubMed ID: 15059069
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Primary prophylaxis of invasive fungal infections in patients with haematologic malignancies. 2014 update of the recommendations of the Infectious Diseases Working Party of the German Society for Haematology and Oncology.
    Tacke D; Buchheidt D; Karthaus M; Krause SW; Maschmeyer G; Neumann S; Ostermann H; Penack O; Rieger C; Ruhnke M; Sandherr M; Schweer KE; Ullmann AJ; Cornely OA
    Ann Hematol; 2014 Sep; 93(9):1449-56. PubMed ID: 24951122
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Central venous catheter-associated fungemia due to Rhodotorula spp. --a systematic review.
    Tuon FF; de Almeida GM; Costa SF
    Med Mycol; 2007 Aug; 45(5):441-7. PubMed ID: 17654271
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Infection by Rhodotorula sp. in children receiving treatment for malignant diseases.
    Pasqualotto GC; Copetti FA; Meneses CF; Machado AR; Brunetto AL
    J Pediatr Hematol Oncol; 2005 Apr; 27(4):232-3. PubMed ID: 15838399
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rhodotorula spp. isolated from blood cultures: clinical and microbiological aspects.
    De Almeida GM; Costa SF; Melhem M; Motta AL; Szeszs MW; Miyashita F; Pierrotti LC; Rossi F; Burattini MN
    Med Mycol; 2008 Sep; 46(6):547-56. PubMed ID: 19180725
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Addition of aerosolized deoxycholate amphotericin B to systemic prophylaxis to prevent airways invasive fungal infections in allogeneic hematopoietic SCT: a single-center retrospective study.
    Morello E; Pagani L; Coser P; Cavattoni I; Cortelazzo S; Casini M; Billio A; Rossi G
    Bone Marrow Transplant; 2011 Jan; 46(1):132-6. PubMed ID: 20383205
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Indications and outcomes of antifungal therapy in French patients with haematological conditions or recipients of haematopoietic stem cell transplantation.
    Herbrecht R; Caillot D; Cordonnier C; Auvrignon A; Thiébaut A; Brethon B; Michallet M; Mahlaoui N; Bertrand Y; Preziosi P; Ruiz F; Gorin NC; Gangneux JP
    J Antimicrob Chemother; 2012 Nov; 67(11):2731-8. PubMed ID: 22850692
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epidemiology, management, and outcome of invasive fungal disease in patients undergoing hematopoietic stem cell transplantation in China: a multicenter prospective observational study.
    Sun Y; Meng F; Han M; Zhang X; Yu L; Huang H; Wu D; Ren H; Wang C; Shen Z; Ji Y; Huang X
    Biol Blood Marrow Transplant; 2015 Jun; 21(6):1117-26. PubMed ID: 25840339
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Safety, clinical effectiveness and trough plasma concentrations of intravenous posaconazole in patients with haematological malignancies and/or undergoing allogeneic haematopoietic stem cell transplantation: off-trial experience.
    Jeong W; Haywood P; Shanmuganathan N; Lindsay J; Urbancic K; Ananda-Rajah MR; Chen SC; Bajel A; Ritchie D; Grigg A; Seymour JF; Peleg AY; Kong DC; Slavin MA
    J Antimicrob Chemother; 2016 Dec; 71(12):3540-3547. PubMed ID: 27521358
    [TBL] [Abstract][Full Text] [Related]  

  • 37. EPICO 3.0. Empirical antifungal therapy in critically-ill hematology patients.
    Llinares P; Ruiz I; Zaragoza R; Ferrer R; Rodríguez AH; Maseda E; Grau S;
    Rev Iberoam Micol; 2016; 33(4):206-215. PubMed ID: 27751781
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Primary antifungal prophylaxis with micafungin in patients with haematological malignancies: real-life data from a retrospective single-centre observational study.
    Nachbaur D; Angelova O; Orth-Höller D; Ditlbacher A; Lackner M; Auberger J; Lass-Flörl C
    Eur J Haematol; 2015 Mar; 94(3):258-64. PubMed ID: 25082655
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Uncommon yeast infections in hematological patients: from diagnosis to treatment.
    Caira M; Trecarichi EM; Tumbarello M; Leone G; Pagano L
    Expert Rev Anti Infect Ther; 2011 Nov; 9(11):1067-75. PubMed ID: 22029524
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pseudozyma spp catheter-associated blood stream infection, an emerging pathogen and brief literature review.
    Siddiqui W; Ahmed Y; Albrecht H; Weissman S
    BMJ Case Rep; 2014 Dec; 2014():. PubMed ID: 25498807
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.